HKPD — Cellyan Biotechnology Cashflow Statement
0.000.00%
Last trade - 00:00- $4.22m
- $5.25m
- $13.43m
Annual cashflow statement for Cellyan Biotechnology, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | 0.998 | 1.33 | -0.027 | -1.14 |
| Depreciation | ||||
| Non-Cash Items | 0 | -0.001 | 0.043 | -0.005 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 0.014 | -2.65 | -0.52 | -0.298 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Accounts Payable | ||||
| Change in Taxes Payable | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | 1.73 | -0.394 | 0.569 | -0.752 |
| Capital Expenditures | -0.118 | -0.088 | -0.155 | -0.043 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | -0.014 | 0.047 | -2.3 | 0.9 |
| Sale of Fixed Assets | ||||
| Change in Net Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -0.132 | -0.041 | -2.45 | 0.857 |
| Financing Cash Flow Items | 0 | 0.164 | 2.92 | 0 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -1.16 | 0.537 | 2 | -0.63 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 0.44 | 0.103 | 0.122 | -0.527 |